Showing results (1091-1100 of 1,667) with videos related to

Sort By:
Pageof 167
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 25, 2016
Cardiophrenic angle lymph node is an indicator of metastatic spread but not specifically peritoneal carcinomatosis in colorectal cancer patients: Results of a prospective validation study in 91 patientsF Jeune, A Brouquet, C Caramella, et al.
Transplantation Proceedings|September 27, 2005
Chronic vascular rejection: histologic comparison between two murine experimental modelsH Yacoub-Youssef, B Marcheix, D Calise, et al.
Nature|February 23, 1984
Induction of altered chromatin structures by simian virus 40 enhancer and promoter elementsJ Jongstra, T L Reudelhuber, P Oudet, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2017
Protective major histocompatibility complex allele prevents type 1 diabetes by shaping the intestinal microbiota early in ontogenyMichael Silverman, Lindsay Kua, Alessandro Tanca, et al.
The American Journal of Pathology|November 7, 2001
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritisA R Pettit, H Ji, D von Stechow, et al.
Molecular Genetics and Metabolism|February 13, 2001
Molecular and structural analysis of two novel mutations in a patient with mut(-) methylmalonyl-CoA deficiencyJ F Benoist, C Acquaviva, I Callebaut, et al.
Dakar Medical|July 29, 2009
[Periodontal conditions in young sickle cell anemia Senegalese patients]H M Benoist, A Seck Diallo, S Diop, et al.
Seminars in Oncology|August 4, 2011
From chemotherapy to targeted therapy in adjuvant treatment for stage III colon cancerAimery de Gramont, Armand de Gramont, Benoist Chibaudel, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2007
Targeting ACE and ECE with dual acting inhibitorsStephen Hanessian, Sébastien Guesné, Ludivine Riber, et al.
Oncotarget|November 12, 2016
Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancerSandrine Tury, Véronique Becette, Franck Assayag, et al.
Pageof 167